Fibroblast growth factor 23 (FGF23), which is a hormone secreted by osteocytes, controls the rate of urinary excretion of phosphate and inhibits renal production of 1,25-dihydroxyvitamin D. This process helps to mitigate hyperphosphatemia in patients with kidney disease. The gene discussed is FGF23; the disease is hyperphosphatemia.